Oxbridge Re (NASDAQ:OXBR – Get Free Report) is expected to release its Q2 2026 results after the market closes on Thursday, August 13th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $1.10 million for the quarter. Parties may visit the the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, August 13, 2026 at 4:30 PM ET.
Oxbridge Re Stock Performance
NASDAQ OXBR opened at $1.31 on Tuesday. The firm has a market capitalization of $10.61 million, a P/E ratio of -5.24 and a beta of 1.94. The stock has a 50-day simple moving average of $1.24 and a two-hundred day simple moving average of $1.07. The company has a debt-to-equity ratio of 0.16, a quick ratio of 8.15 and a current ratio of 8.15. Oxbridge Re has a fifty-two week low of $0.66 and a fifty-two week high of $2.86.
Wall Street Analyst Weigh In
OXBR has been the subject of several recent research reports. Weiss Ratings upgraded Oxbridge Re from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, July 28th. Maxim Group reduced their target price on Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a report on Tuesday, June 16th. Finally, Zacks Research upgraded Oxbridge Re to a “hold” rating in a research report on Wednesday, June 17th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $3.00.
Institutional Investors Weigh In On Oxbridge Re
A hedge fund recently raised its position in Oxbridge Re stock. J.W. Cole Advisors Inc. increased its stake in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) by 106.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 68,000 shares of the insurance provider’s stock after buying an additional 35,000 shares during the quarter. J.W. Cole Advisors Inc. owned about 0.89% of Oxbridge Re worth $90,000 at the end of the most recent reporting period. 5.64% of the stock is currently owned by hedge funds and other institutional investors.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Further Reading
- Five stocks we like better than Oxbridge Re
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
